Implementing a native-language app as a part of a blended care approach in inpatient psychiatric care for refugees

Implementing a native-language app as a part of a blended care approach in inpatient psychiatric care for refugees - I-REACH (Internet based REfugee mentAl healtH Care)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00025972

Enrollment

100

Registered

2021-11-11

Start date

2022-06-01

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F32 F33 F34 F40 F41 F43 F10-F19

Interventions

Group 1: Intervention arm: Blended Care ((Treatment as usual (TAU) + native-language app (blended CETA))

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Refugees from Arabic- and Farsi-speaking countries, signed consent form, current inpatient treatment in one of the participating hospitals, need for mental health care due to depression (F32-F34), anxiety disorder (F40, F41), stress/trauma-associated disorders (F43), mental and behavioral disorders caused by psychotropic substances (F10-F19)

Exclusion criteria

Exclusion criteria: Health conditions that exclude the use of apps, acute suicidality, involuntary inpatient stays (according to a ruling by a judge based on the PsychKG-NRW or the BGB), lack of informed consent, lack of ability to use a smartphone, no sufficient knowledge of Arabic language or Farsi

Design outcomes

Primary

Measure	Time frame
Use of a native-language app during the inpatient psychiatric-psychotherapeutic stay. The primary endpoint is collected using the generated app data.	—

Secondary

Measure	Time frame
Clinical variables, acceptability and usability of the intervention. Parameters will be assessed using routine data and information from interviews with refugees and therapeutic staff. The following parameters will be collected from study patients: - Sociodemographic questionnaire for patients (baseline) - Client Statisfaction Questionnaire (CSQ-8) adapted version (at discharge) - Post Migration Living Difficulties Checklist (PMLD) (baseline) - Therapy Expectancy Questionnaire (baseline) - Health-related quality of life using EQ-5D-5L (baseline, discharge, follow-up) - Questionnaire on the use of services within the health care system (baseline, follow-up). The following instruments will be collected from participating therapists: - Routine data (clinical global impression scale, global assessment of functioning, principal and secondary diagnosis(es), insurance status, date of admission and discharge of patients). - Questionnaire on expectations of the blended care model and the app. - Questions about experiences with the blended care model and with the app.	—

Measure

Time frame

Clinical variables, acceptability and usability of the intervention. Parameters will be assessed using routine data and information from interviews with refugees and therapeutic staff. The following parameters will be collected from study patients: - Sociodemographic questionnaire for patients (baseline) - Client Statisfaction Questionnaire (CSQ-8) adapted version (at discharge) - Post Migration Living Difficulties Checklist (PMLD) (baseline) - Therapy Expectancy Questionnaire (baseline) - Health-related quality of life using EQ-5D-5L (baseline, discharge, follow-up) - Questionnaire on the use of services within the health care system (baseline, follow-up). The following instruments will be collected from participating therapists: - Routine data (clinical global impression scale, global assessment of functioning, principal and secondary diagnosis(es), insurance status, date of admission and discharge of patients). - Questionnaire on expectations of the blended care model and the app. - Questions about experiences with the blended care model and with the app.

—

Countries

Germany

Contacts

Public ContactIsabelle Reinhardt

LVR-Institut für Forschung und Bildung, Sparte Forschung, c/o LVR-Klinik Köln

ireach@lvr.de0221 8993 287

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026